Tag Archives: Healthtech

3Aware and John Snow Labs Announce Partnership to Deliver Multimodal De-Identification Inside the 3Aware Evidence Vault

INDIANAPOLIS, Ind. and LEWES, Del., July 22, 2026 (SEND2PRESS NEWSWIRE) — 3Aware today announced a formal partnership with John Snow Labs to embed their world-class multimodal de-identification capabilities directly within the 3Aware Evidence Vault, enabling health systems to unlock governed, privacy-protected real-world clinical data for scalable research and commercialization—while keeping data and analytic processing inside the provider environment.

Image caption: 3Aware and John Snow Labs Announce Partnership to Deliver Multimodal De-Identification Inside the 3Aware Evidence Vault.

The partnership combines 3Aware’s Evidence Vault model, built to activate longitudinal, multimodal clinical data under each health system’s strict governance and controls, with John Snow Labs’ in-environment de-identification technology for multimodal clinical data, including structured data and unstructured EHR data, PDFs, DICOM, FHIR, and text reports. John Snow Labs’ capabilities—available at no charge to 3Aware’s healthcare provider data partners—are integrated directly into 3Aware’s native data curation and transformation workflow. Together, the companies will help health systems operationalize HIPAA Expert Determination workflows, preserve longitudinal linkage through consistent tokenization, and accelerate the creation of research-ready cohorts without moving raw patient data outside institutional control.

With this foundation in place, 3Aware can scale in silico, non-interventional observational studies by more easily surfacing and interpreting the longitudinal clinical context embedded across complete episodes of care, including the unstructured clinical narrative that structured coding and claims typically miss. Faster de-identification via John Snow Labs reduces the time needed to onboard new health system partners and produce research-ready datasets—supporting both internal KOL-led research and life sciences-funded research collaborations at greater scale—within the 3Aware Evidence Vault. As 3Aware expands from industry-sponsored evidence programs to support investigator-led research within academic medical centers, the combined solution accelerates comparative effectiveness research (CER) and value analysis across interventions, pathways, procedures, and patient subgroups.

“This partnership advances our core principle: health systems shouldn’t have to choose between protecting patient privacy and unlocking meaningful evidence,” said William (Bill) Moss, CEO of 3Aware. “By integrating John Snow Labs’ multimodal de-identification inside the 3Aware Evidence Vault, we’re making it easier for providers to participate as Commercial Data Partners—safely generating scalable, defensible real-world evidence and enabling new, non-reimbursement revenue through governed research collaboration.”

“As healthcare organizations move from pilot projects to scalable secondary use, the ability to de-identify multimodal clinical data where it lives is foundational,” said David Talby, CEO, John Snow Labs. “Partnering with 3Aware brings our de-identification capabilities into a federated evidence infrastructure designed for real operational constraints: governance, auditability, and reliable outputs.”

“For health systems, de-identification is one of the biggest determinants of whether secondary-use research can scale responsibly,” said Neil Martin, former Chief Quality Officer of Geisinger, former Chief Medical Officer of Providence Southern Division, and 3Aware Strategic Advisory Board Member. “Having trusted, world-class multimodal de-identification capabilities embedded directly within the 3Aware Evidence Vault helps mitigate risk and accelerates the ability to participate, so health systems can unlock research value while maintaining the privacy protections and governance patients and institutions expect.”

ABOUT 3AWARE

3Aware provides a Clinical Scientific Workbench and Evidence Vault that enable health systems to generate real-world evidence from longitudinal clinical records—structured and unstructured—processed within the health system’s secure cloud. The platform supports rapid cohort definition, preserves full episode-of-care context, and uses interpretive AI to surface determinant clinical signals for defensible analysis. This model strengthens investigator-led research within partner institutions and enables MedTech manufacturers to run in silico, non-interventional observational studies on devices as used at the point of care. Today, 3Aware supports 15 leading manufacturers, including Medtronic®, Johnson & Johnson®, Boston Scientific®, Stryker®, BD®, Zimmer Biomet®, CONMED®, and Teleflex®. See https://3aware.ai/ for more information.

ABOUT JOHN SNOW LABS

John Snow Labs is a healthcare AI company whose medical language models are used by 500+ enterprise customers across health systems, payers, life sciences organizations, and government agencies. Its de-identification platform removes PHI from structured data, clinical notes, FHIR, PDFs, DICOM, and SVS images, with regulatory-grade accuracy, validated across billions of patient notes and in peer-reviewed research. All processing runs inside the customer’s secure environment: no data leaves institutional control, and every pipeline produces confidence scores and audit logs that meet HIPAA Expert Determination standards. John Snow Labs also provides clinical NLP, medical LLMs, OMOP harmonization, and terminology services that let healthcare and life sciences teams build production-grade data pipelines without moving raw patient records off-premises. See https://www.johnsnowlabs.com/ for more information.

MEDIA CONTACTS
Phil Stoltzfus
VP, Marketing & Public Relations, 3Aware
info@3aware.ai

Kateryna Lee
Head of Marketing, John Snow Labs
kateryna@johnsnowlabs.com

LOGO link for media: https://Send2Press.com/300dpi/26-0722-s2p-3awarejsl-300dpi.webp

NEWS SOURCE: 3Aware

This press release was issued on behalf of the news source (3Aware), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/3aware-and-john-snow-labs-announce-partnership-to-deliver-multimodal-de-identification-inside-the-3aware-evidence-vault/

Amba to Highlight Real-World Results in Webinar on Proactive, AI-Enabled Care

New case study shows sharp reductions in falls, hospitalizations, and missed care tasks at Tiffany Village and Kenny's Pond

NAPLES, Fla., May 14, 2026 (SEND2PRESS NEWSWIRE) — Amba, a leader in passive AI-powered care technology, will host a live webinar titled “From Staffing Crisis To Operational Advantage ” on May 20, 2026, focused on how senior living operators can move beyond reactive care and how working with better visibility and earlier insight improves operational efficiency.

Image caption: Tiffany Village will discuss how its care teams use Amba’s AI-powered passive care technology to reduce falls, hospitalizations, and missed care tasks across its senior living communities in the webinar “Staffing Crisis To Operational Advantage” on May 20, 2026.

The session, presented in partnership with Senior Housing News, will feature Kristen Parsons, President of Tiffany Village and Kenny’s Pond, alongside Amba Founder and CEO Stuart Hamilton. The two will walk through what changed over two years of using Amba, what that shift meant for care delivery, and how teams actually work day-to-day.

Amba uses passive, privacy-first sensors to track patterns in sleep, movement, and behavior, without cameras or audio. Over time, the platform builds a baseline for each resident and flags meaningful changes, helping teams decide when to step in and where to focus their attention.

The system is designed to work within existing environments, allowing communities to adopt it without overhauling infrastructure or workflows.

The webinar follows the release of a new case study based on results from the St. John’s, Newfoundland communities, where Amba has been used to provide care teams with clearer visibility into resident needs, enabling them to step in earlier before an infection or issue arises.

At Tiffany Village and Kenny’s Pond, care teams have seen fewer disruptions and more consistent care. Occupancy increased, and labor costs came down, while care teams reported feeling more confident in how they prioritize their day, in data analyzed from 2023 to 2025:

Result highlights at Tiffany Village and Kenney’s Pond include:

89% reduction in falls
78% reduction in medication issues
97% reduction in hospitalizations

“Amba is very easy to fall in love with,” said Parsons. “Once your team sees the benefit and starts using it every day, it becomes part of how you deliver care.”

These outcomes were achieved without adding staff, challenging the assumption that better outcomes require more staffing.

“Most communities aren’t short on effort; they’re short on visibility,” said Amba’s Hamilton. “When teams can see what’s changing in real time, they don’t have to wait for something to go wrong. They can step in earlier, with more confidence, and focus their time where it actually matters.”

During the webinar, attendees will hear directly from Parsons about what it took to implement the system, where things started to change, and how their approach to care has evolved over time.

Topics include:

How to increase caregiver capacity without adding payroll
Why many systems keep communities stuck in reactive workflows
What proactive care actually looks like in practice
What two years of real data reveal about operations

Webinar Details: The webinar is scheduled for Wednesday, May 20, 2026, at 12 p.m. Eastern. To register or download the case study, visit: https://event.on24.com/wcc/r/5323094/16843E5E12924BD0B946E1C5C11C26D9?partnerref=amba

ABOUT AMBA

Amba is a technology platform designed to support a more proactive approach to care in senior living environments. Using a network of passive, discreet sensors, it continuously monitors patterns related to sleep, movement, and in-room activity without cameras or audio. The platform builds an understanding of each resident’s baseline and surfaces meaningful changes, helping care teams act earlier and focus their attention where it matters most. Designed to work within existing environments, Amba can be adopted without major infrastructure changes, making it easier for communities to improve care consistency and reduce guesswork. Learn more at: https://amba.co/

MULTIMEDIA:

IMAGE link for media: https://www.Send2Press.com/300dpi/26-0514-s2p-amba-300dpi.webp

NEWS SOURCE: Amba

This press release was issued on behalf of the news source (Amba), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/amba-to-highlight-real-world-results-in-webinar-on-proactive-ai-enabled-care/

RespondWell Launches First Telemedicine Platform Built Exclusively for First Responders

Built by active duty first responders, RespondWell gives firefighters, police, EMS, and dispatchers nationwide fast access to licensed health solutions

DENVER, Colo., April 20, 2026 (SEND2PRESS NEWSWIRE) — RespondWell™, a direct-to-consumer telehealth platform designed exclusively for the tactical athlete, officially launched today. The LegitScript-certified platform connects first responders nationwide with licensed healthcare providers and FDA-registered pharmacies to deliver specialized prescription wellness treatments directly to their doors.

Image caption: RespondWell: Built for those who run towards danger.

The platform was built around a simple premise: first responders deserve healthcare that works on their schedule, not the other way around. RespondWell was co-founded by active first responders Joe and Jake, who built the platform after experiencing firsthand the barriers their community faces when accessing consistent, effective healthcare.

“I spent years on the job watching guys push through low T, weight gain, and burnout because the healthcare system made it too hard to get help,” said Joe, co-founder of RespondWell. “We built this because we lived it – and we’re still living it.”

“Six years into the GLP-1 era and guys are still walking out of their doctor’s office with a lecture about eating better and hitting the gym,” said Jake, co-founder of RespondWell. “The access problem didn’t go away. When your life – and the lives of the people counting on you – depend on you being fit for duty, you shouldn’t have to fight your own healthcare system to get there.”

“At RespondWell, performance is a normal conversation,” said Joe. “First responders aren’t cheating and they’re not taking shortcuts. The job destroys your hormones, wrecks your sleep, and grinds down your body. Real, documented physiological consequences of this career – and then the system treats you like you’re asking for something suspicious when you want to fix it. That stops here.”

HOW IT WORKS

Patients complete a brief online health assessment – typically in under 10 minutes. A licensed provider from RespondWell’s partner Medical Group then conducts a clinical evaluation asynchronously where permitted – meaning the provider reviews, assesses, and responds on their end without the patient needing to be present at a specific time. It’s a real medical visit, built around the patient’s schedule instead of the other way around.

Certain treatments, including testosterone replacement therapy, require a video consultation with a licensed provider. The entire process happens online, with no waiting rooms, no in-person visits, and no unnecessary delays. If clinically appropriate, a prescription ships directly from an FDA-registered partner pharmacy. Average turnaround is four hours.

TREATMENT CATEGORIES CURRENTLY AVAILABLE ON THE PLATFORM INCLUDE:

GLP-1 weight management – clinically supervised weight loss programs utilizing customized GLP-1 medications
Testosterone replacement therapy (TRT) – for men experiencing low testosterone, a condition disproportionately affecting those in high-stress occupations
Sexual health – including tadalafil and TriMix for erectile dysfunction, delivered discreetly.
Hormone optimization – enclomiphene and NAD+ for performance and longevity support
Growth hormone support – sermorelin to support recovery, sleep quality, and long-term physical performance in those whose bodies are under sustained occupational stress

All treatments are prescribed by licensed providers and dispensed by FDA-registered pharmacies.

BUILT FOR THE JOB

Research consistently shows that first responders – including the dispatchers who coordinate every call but rarely get counted – face elevated rates of metabolic dysfunction, hormonal imbalance, and weight-related health conditions, driven by irregular sleep, chronic occupational stress, and limited access to consistent care. Despite these known risks, most telehealth platforms are designed for a general population with standard schedules and predictable routines.

RespondWell was purpose-built for the tactical athlete: fast intake, real providers, pharmacy-grade medications, and ongoing follow-up care that doesn’t require the patient to rearrange their shift. The platform is currently available to first responders in all 50 states.

GETTING STARTED

First responders can complete their online health assessment at https://respondwell.health.

ABOUT RESPONDWELL

RespondWell, LLC is a Denver, Colorado-based telehealth technology platform serving first responders nationwide. The platform connects patients with licensed providers from its partner Medical Group and FDA-registered compounding pharmacies for prescription wellness treatments. All clinical decisions are made by independent licensed healthcare providers.

Peak Performance. Mission Ready.

IMPORTANT DISCLAIMERS: The information contained in this press release is for informational purposes only and does not constitute medical advice. Nothing in this release should be construed as a diagnosis, treatment recommendation, or substitute for consultation with a qualified healthcare provider. All treatments referenced are available by prescription only, following an independent clinical evaluation by a licensed provider. Individual results vary. These statements have not been evaluated by the Food and Drug Administration. The treatments and products referenced are not intended to diagnose, treat, cure, or prevent any disease.

MULTIMEDIA:

VIDEO (YouTube): https://www.youtube.com/watch?v=XVh1zoTqsqE

LOGO link for media: https://respondwell.health/assets/respondwell_press_logo.png

NEWS SOURCE: RespondWell LLC

This press release was issued on behalf of the news source (RespondWell LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/respondwell-launches-first-telemedicine-platform-built-exclusively-for-first-responders/

Iota Biosciences Founder to Keynote 2026 Bioelectronic Medicine Forum in NYC

European firms Coherence Neuro and Graphenicalab will present at the meeting, as will U.S. startup firm Spiro Medical

NEW YORK, N.Y., March 5, 2026 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Ninth Annual Bioelectronic Medicine Forum will take place on April 14, 2026. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Photo caption: iota Biosciences CEO Michel Maharbiz will keynote the 2026 Bioelectronic Medicine Forum in New York City on April 14.

Michel Maharbiz, CEO of iota Biosciences, will keynote the conference. The innovative bioelectronic medicine firm spun off from UC Berkeley in 2017 and was acquired by Astellas, a global pharmaceutical company, in 2021 in a deal worth several hundred million dollars. Until 2021, Michel was a full professor and is now an adjunct professor with the department of electrical engineering and computer science at the University of California, Berkeley. Prof. Maharbiz received his B.S. from Cornell University and his Ph.D. from the University of California, Berkeley under nanotechnologist Prof. Roger T. Howe and synthetic biologist Jay D. Keasling.

European firms Coherence Neuro and Graphenicalab will present at the meeting, as will U.S. startup firm Spiro Medical. Venture capital professionals Jeff Chu from Features Capital, Allan Gobbs from ATEM Capital, and Jeffrey Scott Cohen from Ladenburg Thalmann & Co will participate in panels devoted to investment in bioelectronic medicine.

There will also be several informative panel discussions on key topics such as novel diagnostics, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, Victor Pikov, and JoJo Platt will moderate sessions at the event.

Also at the event, Jennifer French, executive director of Neurotech Network, will sit down for a fireside chat with Neurotech Reports editor James Cavuoto for a discussion on the history of the bioelectronic medicine industry.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor. Osypka is the Silver Sponsor.

“Bioelectronic medicine merges some of the best attributes of biopharma and neurotech approaches to treating systemic disorders,” said James Cavuoto, editor and publisher at Neurotech Reports. “This ninth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry.”

For more information on the 2026 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

MULTIMEDIA

Photo link for media: https://www.Send2Press.com/300dpi/26-0305-s2p-Maharbiz-300dpi.webp

Photo caption: iota Biosciences CEO Michel Maharbiz will keynote the 2026 Bioelectronic Medicine Forum in New York City on April 14.

LOGO links:

[1] https://neurotechreports.com/images/bmflogo.jpg

[2] https://www.neurotechreports.com//images/neurotech_business_SimpleBug.png

NEWS SOURCE: Neurotech Reports

This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/iota-biosciences-founder-to-keynote-2026-bioelectronic-medicine-forum-in-nyc/

HIMSS 2026: Future-Proofing the Hospital Digital Front Door – Visit Booth #3461

Visit Booth 3461 for Healthcare Kiosks, Touchless Tech, and Identity Solutions at HIMSS26

WESTMINSTER, Colo., March 2, 2026 (SEND2PRESS NEWSWIRE) — The Industry Group (TIG) and the Kiosk Association (KMA) will present a fully integrated, accessibility-focused self-service ecosystem at HIMSS 2026 (Booth #3461, The Venetian Expo, Las Vegas). With the May 11, 2026 HHS Section 504 deadline approaching, healthcare organizations are facing new enforcement realities around digital accessibility and patient interaction.

Image caption: The Industry Group for HIMSS26 #3461.

The Industry Group invites attendees to Booth #3461 at The Venetian Expo for a hands-on technical briefing of a fully integrated ecosystem designed for the modern hospital campus.

HANDS-ON TECHNOLOGY AT BOOTH #3461:

Touchless Hygienic Screens: Experience HoverTap™, enabling safer interactions across the hospital. This technology works seamlessly with gloves, liquids, and plastic drapes to maintain a sterile environment.
Medical-Grade Durability: Inspect the Insight Touch 21″ Medical AIO, fully 60601-1 certified for clinical environments.
High-Speed Identity: Live demonstrations of secure wristband and badge printing powered by BOCA Systems.
Universal Accessibility: See how Storm Interface assistive hardware integrates with JAWS Kiosk software to create an ADA-compliant and user-friendly experience for all patients.

STRATEGIC BRIEFINGS & LEARNING OBJECTIVES:

Conversational AI: Learn how AI can retrofit existing screens to support 90+ languages, even in high-noise environments.
Regulatory Compliance: Review ADA- and HIPAA-compliant patient check-in workflows and intelligent queue management.
Scalable Signage: Explore solutions ranging from lobby wayfinding to patient-room communication systems.
Operational Modernization: View smart lockers and secure employee vending solutions designed to streamline internal hospital operations.

Pre-book a 15-minute VIP Demo To skip the floor crowds and receive a personalized 1-on-1 walkthrough of our 2026 Compliance Roadmap, attendees are encouraged to schedule a briefing in advance.

Schedule VIP Demo: https://kioskindustry.org/himss-2026-healthcare-kiosks/

“We are entering a critical window for healthcare accessibility,” said Craig Keefner, Editor in Chief. “With the 2026 deadlines approaching, our goal at HIMSS is to provide a clear, technical path forward for providers to remain compliant while improving the patient experience.”

ABOUT THE INDUSTRY GROUP

The Industry Group (TIG) is a central network for self-service technology, encompassing the Kiosk Association (KMA) and specialized portals for retail, healthcare, and digital signage.

MEDIA CONTACT: Craig Keefner craigkeefner@pm.me Text: 720-324-1837

NEWS SOURCE: The Industry Group

This press release was issued on behalf of the news source (The Industry Group), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/himss-2026-future-proofing-the-hospital-digital-front-door-visit-booth-3461/

HealthSync AI Unveils Industry’s First Unified Digital Healthcare Platform (UDHP) to Transform Hospital, Medical Group, and Rural Health System Operations

SAN FRANCISCO, Calif., Nov. 19, 2025 (SEND2PRESS NEWSWIRE) — HealthSync AI, a leader in healthcare automation and AI-native clinical intelligence, today announced the launch of the Unified Digital Healthcare Platform (UDHP), the first end-to-end, AI-orchestrated infrastructure designed to unify fragmented systems across hospitals, medical groups, and rural healthcare providers.

Image caption: HealthSync AI.

The HealthSync UDHP sits above existing EHRs and operational systems, connecting data, workflows, revenue cycle processes, and clinical intelligence into a single, secure, real-time ecosystem. The platform enables healthcare organizations to unlock unified operations without replacing their EHRs or core systems.

“Healthcare doesn’t need another standalone tool, it needs a new foundation,” said Chris Fisher, CEO of HealthSync AI. “Our UDHP architecture solves the systemic issues that EHRs were never built to address. This is the operational backbone that hospitals, clinics, and rural providers have been asking for.”

A NEW ARCHITECTURE FOR A FRAGMENTED INDUSTRY

Most hospitals and clinics rely on hundreds of disconnected applications, leading to data silos, errors, manual work, and multi-day delays in patient and billing workflows. According to a 2024 JAMA Network Open study, only 8–19% of U.S. family physicians report “ideal” interoperability across their systems, with rural providers experiencing significantly worse fragmentation.

HealthSync AI’s UDHP solves this by introducing a unified operational graph that connects data from EHRs, RCM systems, payer portals, telephony, lab systems, and specialty platforms. The platform automates cross-department workflows using a secure, healthcare-specific AI reasoning engine.

CORE COMPONENTS OF THE UDHP

Atrium™ – A HIPAA-native clinical reasoning SLM that powers documentation, coding, decision support, and multimodal understanding.
Voxr9™ – Ambient voice AI that captures clinician–patient conversations in the exam room and generates complete EHR documentation with optional real-time translation.
OmniSync™ – AI voice and chat agents that manage scheduling, intake, triage, and patient communication 24/7.
Pulse3™ – Real-time RCM engine that validates coding, checks eligibility, and drives clean-claim rates up to 98%.
OrchestrAI™ – Workflow automation engine that coordinates clinical and operational actions across systems.
Sentinel™ / EquiScan™ – Continuous governance, audit protection, and equity oversight.

DESIGNED FOR HOSPITALS, MEDICAL GROUPS, AND RURAL HEALTHCARE

The UDHP enables organizations of all sizes to achieve:

30–50% administrative burden reduction
1–2 hours/day returned to clinicians
85%+ workflow automation
Faster revenue cycles and near-zero denials
Improved patient communication and safety
On-premise or private-cloud deployment for PHI control

“Rural and independent clinics have been left behind by traditional interoperability efforts,” said Fisher. “The UDHP levels the playing field by giving them access to the same unified infrastructure as major health systems, without the cost or complexity.”

ABOUT HEALTHSYNC AI

HealthSync AI is a healthcare infrastructure company specializing in AI-driven workflow orchestration, clinical reasoning models, ambient intelligence, and unified data automation. The company’s UDHP powers the next generation of healthcare operations for hospitals, medical groups, and rural health systems.

Learn more at https://www.healthsync.tech/

Press inquiries: chris@healthsync.tech

NEWS SOURCE: HealthSync AI

This press release was issued on behalf of the news source (HealthSync AI), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/healthsync-ai-unveils-industrys-first-unified-digital-healthcare-platform-udhp-to-transform-hospital-medical-group-and-rural-health-system-operations/

Integration Enterprises, PBC, dba Safar, Launches the First Operating System for Human Transformation

Where Neuroscience Meets Human Development - Powered by Salience Intelligence™

WASHINGTON, D.C., Nov. 5, 2025 (SEND2PRESS NEWSWIRE) — Today, Safar (Persian: “Journey”), a dba of Integration Enterprises, PBC, announced the launch of the first Operating System for Human Transformation, introducing a new class of technology that unites neuroscience and human development. Built on Salience Intelligence™, Safar helps coaches, practitioners, and organizations support clients between sessions, where most transformation either consolidates or fades.

Image caption: Integration Enterprises, PBC, dba Safar.

“Every brain has a salience network. A built-in compass that decides what matters now,” said Sabba Nazhand, Founder & CEO of Safar. “Safar mirrors that process. Most systems optimize attention; Safar optimizes transformation without losing the human touch.”

FOR PRACTITIONERS AND ORGANIZATIONS

Safar equips professionals to extend care beyond the room:

Reduce client drop-off from 50–60% to over 80% retention.
Increase lifetime value through sustained engagement.
Streamline session follow-ups and accountability.
Integrate Safar seamlessly with existing workflows.

By leveraging:

Adaptive Protocols that evolve with each client’s engagement and needs.
Voice-to-Voice Emotional Sensing that detects shifts in tone, stress, and readiness.
Outcome Intelligence that integrates validated scales with real-world signals.

Early traction includes 100+ waitlist practitioners, an initial beta cohort, and growing interest from certification programs and marketplaces.

Safar is privacy-first and HIPAA-compliant in its data approach.

Safar extends far beyond the medicalized model. Leadership coaches use it to track behavioral shifts in teams. Health coaches use it to monitor motivation and adherence. Practitioners use it to maintain engagement between sessions. Anywhere human change requires follow-through, an operating system belongs.

Safar draws from the ancestral knowledge of plant medicine traditions, carrying forward their emphasis on relationship, reciprocity, and reflection into contemporary tools for personal and collective healing.

AVAILABILITY:
Safar is opening limited early access to coaches, guides, and training organizations starting today. Request access at joinsafar.com. Only a limited number will be selected.

ABOUT SAFAR:
Safar is the first Operating System for Human Transformation. Tools that help practitioners support clients between sessions, measure progress, and scale what works. Learn more at joinsafar.com.

Safar’s Salience Intelligence™ combines neuroscience, AI, and human-centered design to optimize transformation without losing the human touch.

Learn more or request early access at https://www.joinsafar.com/

MEDIA CONTACT:
Miranda Milbauer
(320) 654-6772
pr@joinsafar.com

MULTIMEDIA:
Logo link for media: https://www.Send2Press.com/300dpi/25-1105-s2p-safar-300dpi.webp

NEWS SOURCE: Integration Enterprises PBC

This press release was issued on behalf of the news source (Integration Enterprises PBC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/integration-enterprises-pbc-dba-safar-launches-the-first-operating-system-for-human-transformation/

Team Recovery Technologies Celebrates Strategic Alignment and Membership Growth with NAATP

SALT LAKE CITY, Utah, May 20, 2025 (SEND2PRESS NEWSWIRE) — Team Recovery Technologies, a leading innovator in alumni engagement technology for behavioral health providers, is proud to recognize its ongoing relationship with the National Association of Addiction Treatment Providers (NAATP) and the NAATP Foundation for Recovery Science and Education (FoRSE).

Photo caption: (L-R) Colton Morgan, Annie Peters, Tristan Brockbank.

As the highest contributor of new Data Sites to FoRSE in the past year, Team Recovery Technologies has not only helped expand the Foundation’s reach but also aligned deeply with its mission to improve addiction treatment through science, technology, and education.

“We believe in what NAATP and FoRSE stand for,” said Preston Dixon, CEO of Team Recovery. “As a company founded by people in recovery, we’re committed to advancing tools and strategies that foster lasting community, client retention, and industry-wide progress. Partnering with NAATP and FoRSE has allowed us to champion that mission on a national scale.”

With over 100 treatment center partners nationwide, Team Recovery’s white-labeled mobile app helps providers build and manage thriving alumni programs. These digital tools improve retention, track outcomes, and reduce readmission costs—key components in a value-based care future.

As the 2025 NAATP National Conference approaches, Team Recovery looks forward to connecting with fellow members, sharing success stories, and continuing to support the collective impact NAATP makes possible.

About Team Recovery Technologies:

Team Recovery Technologies provides mobile app solutions and strategic coaching for behavioral health programs looking to strengthen alumni engagement, improve outcomes, and reduce recidivism. Their technology empowers treatment centers to build community and track results at scale. Learn more: https://www.teamrecovery.io/

About NAATP and FoRSE:

The National Association of Addiction Treatment Providers is a nonprofit professional society of top treatment providers throughout the continuum of care. Since 1978, NAATP has been committed to improving the quality and integrity of addiction treatment. NAATP developed FoRSE in 2020 to support treatment providers in collecting and analyzing data in order to better serve their patients and expand the reach of recovery. Learn more: https://www.naatp.org/

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/25-0520-s2p-team-recovery-300dpi.jpg

Photo caption: (L-R) Colton Morgan, Annie Peters, Tristan Brockbank.

NEWS SOURCE: Team Recovery Technologies

This press release was issued on behalf of the news source (Team Recovery Technologies), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/team-recovery-technologies-celebrates-strategic-alignment-and-membership-growth-with-naatp/

Neurotech Reports Announces First European Leaders Forum

SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference.

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

Tim Denison, Ph.D. FREng, co-founder of Amber Therapeutics, will keynote the conference. Denison also holds a joint appointment in engineering science and clinical neurosciences at Oxford University, where he explores the fundamentals of physiologic closed-loop systems. Prior to that, he was a technical fellow at Medtronic plc and vice president of research & core technology for the Restorative Therapies Group, where he helped oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease.

At the conference, Neurotech Reports editor James Cavuoto will offer an update on the state of the European neuromodulation industry. Neurotech Reports editors JoJo Platt, Jeremy Koff, and Victor Pikov will moderate sessions devoted to peripheral nerve stimulation, bioelectronic medicine applications, venture capital investment, and regulatory and reimbursement issues affecting neurotech startups and emerging firms. Imec executives Peter Peumans, Paru Deshpande, and Barun Dutta (who conceived of, and led the Neuropixels program at imec since its inception) will also offer updates on technology advances at the European research and innovation center.

Executives from several emerging neurotechnology startups, including Italian firm WISE srl and German firm Precisis, will also present at the conference during multiple entrepreneur panels. In addition to imec, sponsors of the conference include Cirtec Medical, MST, Valtronic, and Osypka.

Neurotech Reports will also produce the 8th Annual Bioelectronic Medicine Forum on April 10, 2025 in New York City, and the 25th Annual Neurotech Leaders Forum San Francisco, on November 5-6, 2025.

For more information, contact Neurotech Reports at 415 546 1259 or visit: https://neurotechreports.com/pages/leadersforum-europe.html.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0130-s2p-ntrep-timdenison-300dpi.jpg

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-first-european-leaders-forum/

Olea Kiosks Unveils its Chicago Healthcare Check-In Kiosk: Enhancing Patient Experience with ADA-Compliant Design

LOS ANGELES, Calif. /ScoopCloud/ -- Olea Kiosks®, Inc. is excited to announce the launch of its latest advancement in healthcare technology, the Chicago Healthcare Check-In Kiosk. This innovative and inclusive solution offers a sleek, modern ADA-compliant design, elevating the user experience for all.

One of the standout features of the Chicago is its commitment to accessibility. This new design includes an offset monitor to provide easier wheelchair access and a tilt bracket to assist people of all heights. For those with low vision, the unit includes the thoughtful integration of an Audio Nav system and a keyboard to improve the user experience.

"This new design is the result of conversations with many healthcare companies that are all trying to figure out how to implement self-service properly. We wanted to ensure it addressed ADA, but not just for the sake of checking boxes, but making it user-friendly and comfortable for all users," explained Frank Olea, CEO.

"We also wanted to offer facial recognition as part of the standard product because that requirement is coming soon, so we incorporated the camera and the tilt bracket to ensure the picture can be taken properly regardless of height. You're juggling HIPPA and several requirements into one design so we're proud to deliver a kiosk that is better designed and includes more features and is better value than what's on the market today," added Olea.

The Chicago is available in three form factors: a Height-Adjustable, Freestanding and Desktop.

By streamlining the check-in process, healthcare providers can reduce wait times, optimize staff efficiency, and ultimately enhance patient satisfaction.

For more information on the Chicago Healthcare Check-In Kiosk, visit https://www.olea.com/product/chicago-healthcare/

A first-customer deployment of the Chicago kiosk is anticipated to be operational by the end of October.

About Olea Kiosks, Inc.:

Olea Kiosks® Inc., is a self-service kiosk solution provider for government, healthcare, hospitality, travel, and entertainment. Its technologically advanced, in-house manufacturing, design, and innovation have made it an industry leader. Headquartered in Los Angeles, California, customers include Cincinnati Children's Hospital, Geisinger, Greyhound, Johns Hopkins, Kaiser Permanente, SmarteCarte, Subway Sandwiches, and Universal Studios. Olea Kiosks can be found wherever high-volume authentications and transactions are required, including 50+ major airports, amusement parks, and premier stadiums across all 5 major US sports leagues.

For more information, visit https://www.olea.com/.

Olea Kiosks®, Inc. is excited to announce the launch of its latest advancement in healthcare technology, the Chicago Healthcare Check-In Kiosk. This innovative and inclusive solution offers a sleek, modern ADA-compliant design, elevating the user experience for all.

Related link: https://www.olea.com/

Mopec Group Unveils Next-Generation Maestro Grossing Station: The Mopec Maestro Encore

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec Group, a leading pathology technology company and manufacturer anatomic pathology equipment & supplies, is proud to announce the launch of the Mopec Maestro Encore, the latest advancement in grossing station technology. This release marks a significant milestone in Mopec Group's strategic effort to emphasize innovation and integration of cutting-edge digital solutions as the standard for improving pathology workflow.

The Mopec Maestro Encore now features Mopec's state-of-the-art digital pathology solution, PathCam, as a standard inclusion in every unit. PathCam boasts automated image enhancement, seamless integration with laboratory information systems (LIS), and advanced annotation capabilities. Additionally, Mopec PathCam(r) is designed to for frictionless integration with the leading Electronic Health Record (EHR) system. The Encore's hardware integration lays the groundwork for future developments in incorporating AI technology into Mopec's digital pathology platform, further solidifying the company's commitment to technological innovation.

"We are excited to introduce the Maestro Encore as the new benchmark in grossing station technology," said Francis X. Dirksmeier, CEO of Mopec Group. "This product embodies our mission to empower pathology and anatomy professionals with the leading platform of products and solutions for the advancement of diagnostic accuracy, safety, research, education, and the treatment of disease."

The Maestro Encore also features the patented SafeDraft(tm) Ventilation Technology, which directs air from the cutting surface's front to the back, establishing a laminar flow pattern that enhances the effectiveness of the robust backdraft technology. This consistent ventilation is crucial in safeguarding users against potential hazardous formalin exposure.

Additionally, the new OrchestraOS introduces configurable notifications and alerts for everything from reduced airflow to filter replacements, ensuring user safety remains paramount. The easy-to-change Integrated Air Filtration System further optimizes airflow, mitigating and preventing formalin exposure risks.

"With the Maestro Encore, we are not just offering a high-quality piece of equipment; we are providing an integrated technology platform that enhances the entire pathology workflow," said Michael McClain, Vice President of Technology at Mopec Group. "This innovation is the first step towards a future where AI technology will revolutionize anatomic pathology workflow."

Jeff Pemberton, Vice President of Marketing & Commercial Strategy, added, "The Maestro Encore is a testament to Mopec Group's dedication to leading the industry with innovative, technology-driven solutions that prioritize both safety and efficiency. We are proud to continue supporting pathology professionals with the tools they need to achieve excellence in their work."

The Mopec Maestro Encore is now available for order. For more information, visit https://www.mopec.com/maestro or contact Mopec Group's sales team.

About Mopec:

As a division of Mopec Group, Mopec is guided by our mission to empower pathology & anatomy professionals with the leading platform of products and solutions for the advancement of diagnostic accuracy, safety, research, education, and the treatment of disease. This mission has driven us to become the leading experts on anatomic and forensic pathology equipment and workflow. We've been working hand-in-hand with pathology professions for over 30 years developing systems and solutions that facilitate safer gross examinations.

As anatomic pathology as evolved, Mopec Group has been at the forefront, getting feedback, improving design, and solving problems. Our unwavering dedication to excellence is underscored by the widespread installations within America's premier healthcare institutions, a testament to our continuous pursuit of providing cutting-edge tools that significantly contribute to the progress and safety of pathology and anatomy professionals worldwide. We are innovators. We are collaborators. We are grossing. Learn more: https://www.mopec.com/

Mopec Group, a leading pathology technology company and manufacturer anatomic pathology equipment & supplies, is proud to announce the launch of the Mopec Maestro Encore, the latest advancement in grossing station technology. This release marks a significant milestone in Mopec Group's strategic effort to emphasize innovation and integration of cutting-edge digital solutions as the standard for improving pathology workflow.

Related link: https://www.mopec.com/

WellVisor Partners with FlexCare Digital Health to Expand Services for Clients

ATLANTA, Ga. /ScoopCloud/ -- WellVisor, a nationwide leader in Integrated Health & Wellbeing, announced today its partnership with FlexCare, LLC, to provide employers and benefit plans the most comprehensive, integrated health and wellness solution available. This partnership allows WellVisor's employers and their members to benefit from FlexCare's comprehensive solution. WellVisor and FlexCare will start their partnership immediately to further simplify the delivery of employee benefit tools for improving lives and lowering costs.

"WellVisor is excited to welcome FlexCare to our integrated suite as we continue to simplify the employee benefits experience with all the best health and wellbeing solutions available in one place," said WellVisor Co-founder and CEO, Patrick Cooper.

Approximately 85% of employees are confused about their employee benefits (*note 1), and 62% of employees lose 32 days per year navigating workplace apps (*note 2). The growing trend of disconnected benefits not only increases costs and lowers engagement, it also further complicates the delivery and use of solutions that improve lives and lower healthcare costs for everyone. With WellVisor and FlexCare seamlessly working together in the WellVisor solution, employees and their family members now have one less app to learn to fully take advantage of their employee benefits.

"FlexCare is excited to partner with WellVisor to expand our opportunities in the employer market. We view this as a tremendous opportunity to simplify the delivery of our valuable benefit to employers and their employees," said FlexCare Founder & CEO Lee Shoemake.

"While FlexCare already has one of the highest utilization rates among virtual care providers, we are always looking for new ways to simplify delivery and increase utilization. Through this partnership and WellVisor's ability to educate members on the benefits and services available to them, we predict members will be even more aware of their FlexCare options and more likely to take advantage of our quicker, cost-saving, virtual care services."

About WellVisor:

WellVisor is the nation's only fully integrated health and wellbeing solution for employers, benefit plans, and health systems. Our single solution approach and unique AI personalized one-step-at-a-time guidance bring the best possible care to employees and their family members.

Website: https://www.wellvisor.com/

About FlexCare:

FlexCare, LLC is a leading digital health provider of online and on-demand healthcare delivery services to private and public employers, associations, brokers, school systems and more. By using digital health services instead of more expensive urgent care and ER visits, FlexCare's digital health services cuts unnecessary costs and keeps members smiling (instead of waiting).

In addition to telemedicine and the WellVisor health and wellbeing tools, FlexCare also provides Virtual Primary Care, Dermatology, TeleDentistry, Behavioral Health and Telespine benefits.

Using their proprietary online administrative system, FlexCare seamlessly provides multiple employee benefits either bundled or unbundled which makes for ease of administration for employers.

Resource Links:

Website: https://flexcare.com/

Dashboard: https://www.myflexcare.com/

Twitter: https://twitter.com/FlexCarePlus

LinkedIn: https://www.linkedin.com/company/flexcare-telemedicine/?viewAsMember=true

Facebook: https://facebook.com/FlexCarePlus

Instagram: https://instagram.com/FlexCarePlus

Notes / Sources:

*1 https://www.forbes.com/sites/forbeshumanresourcescouncil/2023/04/26/personalization-is-the-future-of-employee-benefits/?sh=1da78f475335

*2 https://www.ringcentral.com/whyringcentral/company/pressreleases/pressreleases-2018/report_app_overload_is_creating_chaos_at_work_and_costing_businesses_billions.html

WellVisor, a nationwide leader in Integrated Health & Wellbeing, announced today its partnership with FlexCare, LLC, to provide employers and benefit plans the most comprehensive, integrated health and wellness solution available. This partnership allows WellVisor's employers and their members to benefit from FlexCare's comprehensive solution. WellVisor and FlexCare will start their partnership immediately to further simplify the delivery of employee benefit tools for improving lives and lowering costs.

Related link: http://flexcare.com/

Introducing the Cellular 2 Device: Soberlink’s Latest Advancement in Remote Alcohol Monitoring

HUNTINGTON BEACH, Calif. /ScoopCloud/ -- Introducing the new Cellular 2 Device, the latest addition to Soberlink's line of remote alcohol monitoring solutions. Designed with user convenience and global accessibility in mind, the Cellular 2 Device seamlessly combines a sleek design with comprehensive functionality, offering a dependable tool for individuals and professionals in Family Law, Addiction Recovery, and Workplace Compliance.

Enhanced Design and Global Connectivity

The new Cellular 2 Device builds upon the strengths of Soberlink's previous models, featuring a slimmer, more modern form factor and a superior battery life of 14+ days. With its built-in cellular module, the device ensures users can submit tests from anywhere in the world, connecting them to a network of global LTE coverage.

Reliable Test Storing Feature

A key feature that continues to distinguish the Cellular 2 Device is its reliable test storing function. In situations where cellular connectivity is unavailable, the Cellular 2 Device securely stores test data, proactively attempting to transmit stored tests until a connection is restored. This feature ensures that tests are recorded and reported accurately on Soberlink's Advanced Reporting. These calendar-format reports utilize AI to reconcile the time-stamped tests, accurately reflecting the time they were taken, rather than when they were transmitted. The consistent retention and precise reporting of tests during connectivity outages are crucial to Soberlink's commitment to reliability and earning the trust of users.

Simplified User Experience

Aiming to make alcohol monitoring even more straightforward and less intrusive, the Cellular 2 Device boasts an intuitive interface with an LED screen and simple navigation buttons. Enhanced by a device leveling feature that guides users to hold the device in a way that is optimal for built-in facial recognition, the Cellular 2 Device ensures an efficient and smooth user experience.

Testimonials from Cellular 2 Users

"I like the fact that I do not have to hold my cell phone up while taking my test. Makes everything much easier and user friendly."

"The Cellular 2 Device is wonderfully portable."

"It's much easier for travel."

"Thankfully, the device will store tests. Otherwise, I would be dead in the water."

"It is super easy to use... Been using it for a few weeks and only charged it once."

Recognition from Industry Professionals

The functionality and design of Soberlink's devices have garnered positive feedback from various sectors.

Nicola Donaldson, Certified Supervised Counselor, has praised the device, mentioning how, "Soberlink just ticked all the boxes in terms of convenience, portability, and user friendliness. We were really impressed with just how easy it all is."

Family Law professional Sean Wirth also recognizes the value of Soberlink, stating, "I trust [Soberlink] because it's an all-in-one device. You have the facial recognition built-in to a reliable breathalyzer device with real-time results. It just provides a great product for Family Law practitioners and clients."

Dedicated to Quality and Innovation

The Cellular 2, like all Soberlink devices, undergoes a meticulous design, development, testing, and manufacturing process in the United States. This dedication ensures that Soberlink continues to provide reliable, accurate, and high-quality solutions to support accountability for sobriety.

The introduction of the Cellular 2 Device marks a significant achievement as Soberlink strives to continue delivering enhanced and simplified experiences in remote alcohol monitoring. Soberlink invites you to explore the capabilities of the Cellular 2 Device.

Learn more: https://www.soberlink.com/cellular-alcohol-monitoring-device

About Soberlink:

Soberlink supports sobriety accountability with its alcohol monitoring system, combining professional-grade breathalyzers with cutting-edge connectivity. Trusted by professionals in addiction recovery, workplace compliance, and family law, Soberlink's solutions are designed to offer reliability, convenience, and peace of mind.

For additional information about the Cellular 2 Device and Soberlink's full range of products, please visit https://www.soberlink.com/.

MULTIMEDIA:

VIDEO (YouTube): https://youtu.be/U0y_YBYFQBk

Introducing the new Cellular 2 Device, the latest addition to Soberlink's line of remote alcohol monitoring solutions. Designed with user convenience and global accessibility in mind, the Cellular 2 Device seamlessly combines a sleek design with comprehensive functionality, offering a dependable tool for individuals and professionals in Family Law, Addiction Recovery, and Workplace Compliance.

Related link: https://www.soberlink.com/

Emerging Neurotechnology Startups to Present at 2023 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Among the new and emerging neurotech firms presenting at the conference are Opto Biosystems, a U.K. developer of novel diagnostics for brain cancer, NeuraLace Medical, a San Diego-based manufacturer of noninvasive therapies for treating chronic pain, Spark Biomedical, a Texas firm developing noninvasive therapies for treating addiction, and Harmonic Pain Solutions, an Atlanta, GA-area developer of wearable pain devices that use mechanical stimulation.

Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address on the morning of November 6. He will speak on the topic "New Directions in Neuromodulation."

Daniel Kraft, founder of NextMed Health, chair of medicine for Singularity University, and chair of the XPrize Pandemic & Health Alliance, will deliver a keynote address on November 7 devoted to the topic, "The Future of Health and Medicine: Where Can Technology Take Us?" Kraft is board certified in internal medicine and pediatrics and completed fellowships in hematology/oncology and bone marrow transplantation at Stanford. He has given six TED & TEDMED talks.

Another featured presenter will be Prasad Shirvalkar, an associate professor at UC San Francisco School of Medicine, who recently co-authored a seminal paper relating to pain biomarkers. Chris Rozell, a professor at Georgia Tech, who recently coauthored a paper on biomarkers for depression, will also make a presentation at the event.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled "Neurotech Investment: Bouncing Back from the Downturn," which will feature advice and recommendations from several venture capital professionals, including Sara Shnider from Joy Ventures, Martin Dieck from Neurotechnology Investors, and Suraj Mudichintala from Action Potential Venture Capital.

Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled "Changing Landscape: New SCS and PNS Vendors Enter the Scene," which will examine the current competitive environment in neuromodulation. Neurotech Reports editor James Cavuoto will moderate a session titled "Interpreting the Data: Neuromodulation Vendors Ward Off Negative Publications. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled "Choosing Our Role Models: What Neurotech Can Learn from Other Healthcare Industries."

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic, Velentium, Focus, Neo-Bionica, and Iris Biomedical are Silver Sponsors, while TTP and Microdul are Bronze sponsors.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Elevate Your Addiction Treatment Approach: Discover Soberlink’s Groundbreaking Strategies for the Future of Addiction Medicine, Featured in USA Today’s Mental Health Magazine

HUNTINGTON BEACH, Calif. /ScoopCloud/ -- Soberlink, a recognized leader in addiction treatment solutions, has been featured in a special edition of USA Today's Mental Health Magazine focusing on the future of addiction medicine.

In a display commissioned by the magazine, Soberlink showcased its innovative strategies and solutions that help to shape the future landscape of addiction treatment. The feature allows addiction treatment professionals a glimpse into the pioneering technologies and methodologies that Soberlink is bringing to this critical field.

Thy-An Tran, Director of Marketing and Advertising, expressed excitement over this opportunity to highlight the company's innovative role in the future of addiction treatment: "Being able to share our technology with a wider community through USA Today's Mental Health Magazine is such a great chance to raise awareness about the effectiveness and benefits of our system. We firmly believe that accountability, sustained motivation, and trust rebuilding, as facilitated by Soberlink, are the cornerstones of successful addiction treatment now and into the future."

Soberlink's feature in the nationally acclaimed magazine underscores the company's commitment to revolutionizing the addiction treatment space, providing unparalleled value to practitioners, and continually evolving to meet the needs of those struggling with addiction.

Soberlink's state-of-the-art alcohol monitoring system, complete with facial recognition, tamper detection, and AI-powered Advanced Reporting, is defining the future of alcohol addiction treatment.

Soberlink's pioneering role in the future of addiction medicine, coupled with its unwavering dedication to improving treatment outcomes, empowers addiction treatment professionals to improve their practices and, ultimately, patient lives.

For more information about Soberlink's advanced solutions and insights into the future of addiction treatment, visit https://www.soberlink.com/.

About Soberlink:

Soberlink strives to erase the stigma of alcohol monitoring by designing and developing the very best technology for a modern, discreet user experience. We empower treatment professionals to provide unprecedented support for their clients' sobriety journey. Through our comprehensive alcohol monitoring system, we enable individuals to demonstrate their commitment to recovery, thereby fostering trust, rebuilding relationships, and improving lives. Our journey started in 2011, and ever since, we've been fueled by a passion for creating innovative solutions that make alcohol monitoring not only dependable but also seamlessly integrated into everyday life.

Soberlink, a recognized leader in addiction treatment solutions, has been featured in a special edition of USA Today's Mental Health Magazine focusing on the future of addiction medicine. Soberlink's state-of-the-art alcohol monitoring system, complete with facial recognition, tamper detection, and AI-powered Advanced Reporting, is defining the future of alcohol addiction treatment.

Related link: https://www.soberlink.com/

ADA Compliance and Digital Kiosks: Ensuring Accessibility in Healthcare Settings

DENVER, Colo. /ScoopCloud/ -- Kiosk Innovations, a U.S. based digital kiosk manufacturing company, would like to inform the various stakeholders within the healthcare industry about the importance of digital kiosks in the medical field and emphasize the need for ADA compliance to ensure equal access and inclusion for all patients. Consulting with experts, such as Kiosk Innovations, can maximize inclusion and efficiency in implementing self-service solutions.

Digital kiosks serve an increasingly wide variety of tasks in today's society. It is no question these terminals can efficiently provide services in healthcare by completing tasks such as wayfinding directions as well as self service check into Epic's Welcome or other EHR systems. Being the patients first impression of a medical group, it is important that these devices are noticeable, welcoming, and easy to use for patients to ensure the patient's journey is fluid which ultimately increases adoption rates in this technology and helps instill confidence in patients.

It is important to understand the demographic of the typical healthcare patient. In many cases these individuals are older and/or may have a higher rate of disability (whether temporary or permanent) than the average US population. Healthcare providers have both an ethical and legal obligation to provide the same level of service to patients with common disabilities. ADA compliance is clearance and reach for those who are wheelchair bound, an audible form of navigation and either tactile or voice recognition for those who are visually impaired, or visual cues for those with auditory impairments.

To fulfil your legal obligations and be ADA compliant one must understand what information is being communicated, what tasks are to be completed, and provide equal access to this information as well as provide an equal amount of privacy. Not providing an equally accessible solution can result in legal ramifications, ethical shortcomings, reputational damage, and a lower adoption rate.

ADA compliance should not just be a legal requirement. Providing equal access and inclusion is the right thing for so many more reasons than just legal ramifications. Ensuring a digital self-service solution is ADA compliant ensures individuals remain autonomous. This allows a much larger range of patience that can complete tasks more efficiently, having a larger pool of patience that can help themselves helps drive organizational efficiencies.

The purpose of self service is to drive efficiency to patients as well as the organization, the greater accessibility the larger the pool of users, the larger the pool of users, the more efficiency gained. Self-service is a tool, the consultant at Kiosk Innovations can help guide you towards a solution that maximizes inclusion for your patients and efficiency for your organization.

To learn more visit: https://kioskinnovations.com/.

About Kiosk Innovations:

Based in Denver, Colorado, Kiosk Innovations is an employee-owned company that supports and nurtures the essence of what is required to give customers the quality solutions they need - INNOVATION. We are proud to produce unique and original designs that not only stand out from their surroundings, but incorporate ever-changing technological advancements as they are introduced to the industry.

With more than 30 years of experience, the Kiosk Innovations team has extensive knowledge of evolving kiosk applications, and we design and manufacture everything in-house to ensure tight quality control while keeping costs competitive. Combining first-rate knowledge and field experience with creative vision and passion, Kiosk Innovations strives to provide the very best customer service and experience.

Kiosk Innovations, a U.S. based digital kiosk manufacturing company, would like to inform the various stakeholders within the healthcare industry about the importance of digital kiosks in the medical field and emphasize the need for ADA compliance to ensure equal access and inclusion for all patients. Consulting with experts, such as Kiosk Innovations, can maximize inclusion and efficiency in implementing self-service solutions.

Related link: https://kioskinnovations.com/

Embrace the Power of Proof: How Documenting Sobriety Can Restore Relationships and Boost Confidence in Addiction Recovery for Mental Health Awareness Month

HUNTINGTON BEACH, Calif. /ScoopCloud/ -- In anticipation of Mental Health Awareness Month this May, Soberlink, the leading alcohol monitoring technology for documenting proof of sobriety, is excited to launch its inspiring "Proof is Powerful" initiative. This campaign aims to emphasize the life-changing impact of proving sobriety in healing relationships and bolstering confidence during the recovery process.

By sharing the moving stories of Soberlink clients who have successfully rebuilt their lives and relationships, the "Proof is Powerful" initiative brings attention to the significance of the little green checkmarks on a Soberlink calendar. As individuals demonstrate their commitment to sobriety, they progressively restore trust with their loved ones, creating a supportive environment for enduring recovery. The campaign poses the question: Can something as simple as proving sobriety truly be the key to unlocking this healing process?

Grant, a former Soberlink client, witnessed this transformative power firsthand. Initially hesitant to use Soberlink, Grant soon recognized the positive impact it had on his relationships with those around him. By documenting and proving his sobriety through Soberlink, Grant was able to regain trust, mend relationships, and renew his dedication to a healthier, sober life, along with a rewarding new career.

"For me, Soberlink was a crucial accountability tool. It was the guardrail that kept me from veering off the road to recovery," says Grant. "Soberlink also provided evidence of change that helped me regain the trust of my family. With the help of Soberlink and other support, I learned that recovery was not only possible but also enjoyable and rewarding. So much so that it inspired a career change and led me to work for an organization whose mission is to help people struggling with alcohol and drug use disorders find quality treatment appropriate for their needs."

For more on Grant's story, click here: https://www.shatterproof.org/blog/my-journey-through-alcohol-addiction

Aligned with the spirit of Mental Health Awareness Month, Soberlink's "Proof is Powerful" initiative strives to shift the conversation around proving sobriety by showcasing its potential to heal, rebuild, and empower those in recovery. The campaign aims to promote a supportive and empathetic environment for individuals on their path to sobriety.

LEARN MORE: https://www.soberlink.com/proof-is-powerful

About Soberlink:

Soberlink is the leading remote alcohol monitoring technology company that provides documented proof of sobriety. The company's technology includes a portable breathalyzer device and a cloud-based system that monitors and reports sobriety in real-time. Soberlink's strives to support individuals on their recovery journey by providing a technology that promotes accountability, builds trust, and empowers lasting recovery. The "Proof is Powerful" initiative is just one example of Soberlink's commitment to promoting a supportive and empathetic environment for those in recovery.

To learn more about Soberlink and its products, visit https://www.soberlink.com/.

In anticipation of Mental Health Awareness Month this May, Soberlink, the leading alcohol monitoring technology for documenting proof of sobriety, is excited to launch its inspiring "Proof is Powerful" initiative. This campaign aims to emphasize the life-changing impact of proving sobriety in healing relationships and bolstering confidence during the recovery process.

Related link: https://www.soberlink.com/

OverSightMD Inc. Launches Connected Therapy Cloud and Hourly Relapse Monitoring Service for Individuals with Substance Use Disorder

SILICON VALLEY, Calif. /ScoopCloud/ -- OverSightMD Inc. announces the launch of Connected Therapy Cloud℠, a revolutionary solution for return-to-use prevention and ongoing relapse management for individuals struggling with Substance Use Disorder (SUD). Connected Therapy Cloud will provide hourly relapse rounding by specialized nurses and immediate coordination with their therapist.

According to a report by the National Survey on Drug Use and Health (NSDUH), approximately 40.3 million adults aged 12 years and older had a substance use disorder in the US in 2020. Managing relapse is one of the most significant challenges of addiction treatment. Connected Therapy Cloud forms a continuous therapy link between a therapist and their patient by providing a connected platform, which incorporates the expertise of specialized nurses, patient-reported data, and wearable technology to detect early signs of return-to-use.

Connected Therapy Cloud enables specialized virtual OverSightMD nurses to take the lead in hourly relapse rounding, which helps to identify potential signs of return-to-use in time and take proactive measures to provide timely interventions as needed. The platform also allows for secure and easy communication between the patient's clinical team and therapist, ensuring coordinated and integrated care.

Connected Therapy Cloud is customizable based on the patient's relapse risk, with round-the-clock monitoring available to fit the individual's unique needs. This tailored approach ensures that patients receive the support they need when they need it, ultimately improving the quality of care, reducing the likelihood of preventable readmissions, and improving relapse management.

The Founder and CEO of OverSightMD, Mark Godwin, said, "We are thrilled to offer Connected Therapy Cloud as a comprehensive solution to help individuals struggling with Substance Use Disorder to manage their addiction and improve their overall wellness. With this, we hope to reduce the number of relapses and hospitalizations related to substance use disorder and, ultimately, enhance care for the patients and the clinical teams who provide them with quality care."

For more information on Connected Therapy Cloud℠ for providers, please visit the company website at https://oversightmd.com/connected-therapy-cloud-providers/.

About OverSightMD Inc.:

OverSightMD (https://oversightmd.com/) Founded in 2013, OverSightMD Inc. is a leading integrated health management company providing healthcare solutions tailored for hospital systems, providers, and employers. The OverSightMD platform integrates state-of-the-art technology with an experienced clinical team of physicians, nurses, behavioral health clinicians, and care coordinators continuously monitoring and screening the well-being of patient populations. Their personalized patient care approach encompasses data tracking from various sources, including self-reported symptoms, nurse wellness calls, advanced RPM, and wearable devices. Their proactive intervention strategy aims to improve daily health management and prevent incidents like disease relapse, unnecessary ER visits, and hospital readmissions.

MULTIMEDIA:

LOGO link for media: https://www.Send2Press.com/300dpi/23-0425-s2p-oversightmd-300dpi.jpg

OverSightMD Inc. announces the launch of Connected Therapy Cloud℠, a revolutionary solution for return-to-use prevention and ongoing relapse management for individuals struggling with Substance Use Disorder (SUD). Connected Therapy Cloud will provide hourly relapse rounding by specialized nurses and immediate coordination with their therapist.

Related link: https://oversightmd.com

OverSightMD Inc. Expands Nationwide to Support Hospital-at-Home Programs with Hourly Virtual Rounding and Post-Acute Provider Care Management

SILICON VALLEY, Calif. /ScoopCloud/ -- OverSightMD Inc., a leading integrated health management company, is expanding its Hourly Virtual Rounding and Post-Acute Provider Care Management solution nationwide. The solution is designed to support hospitals operating hospital-at-home programs, delivering hourly virtual nurse rounding, continuous patient monitoring, data analysis, and screening the well-being of each patient for the hospital-at-home clinical team. Additionally, when a patient is discharged from a hospital-at-home program, OverSightMD's service continues for 30, 60, or 90 days, assuring proactive patient care management from skilled nursing facilities and home health agencies.

OverSightMD's Hourly Virtual Rounding prevents chronic diseases from recurring among patients during and after being discharged from the hospital-at-home program. This innovative solution combines telemedicine and continuous remote monitoring to offer patients real-time access to their existing healthcare providers and care teams. With OverSightMD's experienced clinicians conducting hourly check-ins, reviewing patient data, and collaborating with hospital physicians and nurses in delivering individualized care to each patient, the solution is geared towards enhancing patient experience, improving outcomes, and reducing readmission rates by 15 percent or more.

"Our Hourly Virtual Rounding and Post-Acute Provider Management solution are designed to eliminate preventable hospital readmissions that cost Medicare an estimated $17 billion to $20 billion annually," stated Mark Godwin, CEO of OverSightMD. "We are excited to expand nationwide, providing streamlined and integrated care coordination to patients discharged to and from hospital-at-home programs while reducing ER visits and hospital readmissions."

OverSightMD's Hourly Virtual Rounding and Post-Acute Provider Management solution are now available nationwide to all hospital systems.

To learn more about the solution and its benefits to hospitals with a hospital-at-home program and rural hospitals with limited access to care, visit https://www.oversightmd.com/.

About OverSightMD Inc.:

Founded in 2013, OverSightMD Inc. is a leading integrated health management company providing healthcare solutions tailored for hospital systems and employers. The OverSightMD platform integrates state-of-the-art technology with an experienced clinical team of physicians, nurses, behavioral health clinicians, and care coordinators continuously monitoring and screening the well-being of patient populations. Their personalized patient care approach encompasses data tracking from various sources, including self-reported symptoms, nurse wellness calls, advanced RPM, and wearable devices. Their proactive intervention strategy aims to improve daily health management and prevent incidents like relapse, unnecessary ER visits, and hospital readmissions.

OverSightMD Inc., a leading integrated health management company, is expanding its Hourly Virtual Rounding and Post-Acute Provider Care Management solution nationwide. The solution is designed to support hospitals operating hospital-at-home programs, delivering hourly virtual nurse rounding, continuous patient monitoring, data analysis, and screening the well-being of each patient for the hospital-at-home clinical team.

Related link: https://oversightmd.com

Beth A. Wilson Named New President of Excelas, LLC

CLEVELAND, Ohio /ScoopCloud/ -- Beth A. Wilson has been named President of Excelas, LLC, a national provider of medical record organization, retrieval, and analysis, helping healthcare organizations respond to claims - and litigation - brought against them. Excelas, LLC's announcement today says Ms. Wilson's tenure begins April 17, 2023.

As Senior Counsel with HCR ManorCare/ProMedica Health System since 2009, Ms. Wilson has been responsible for resolving legal matters involving patient care with a nationwide network of hospitals, skilled nursing and rehabilitation centers, assisted living facilities, outpatient rehab clinics, and home health and hospice.

Graduating Magna Cum Laude from the University of Toledo, Ms. Wilson was awarded her Juris Doctor degree from University of Toledo Law School Magna Cum Laude as the top-ranked female student, and inducted into the Order of the Coif (top 10% of law school class). She joined Cooper & Walinski, which in 2007 became the largest majority women-owned firm in the country, became a partner within five years, and then was elected to the firm's Board of Directors.

A 20 Under 40 Award recipient, recognizing distinguished individuals in the community, Ms. Wilson has advocated on behalf of individuals with disabilities to obtain reasonable accommodations, and sought Civil Protective Orders pro bono for victims of domestic violence. Her time and talents have also benefitted United Way, American Heart Association, American Cancer Society, Habitat for Humanity, Assistance Dogs of America, The Toledo Zoo, and Advocates for Basic Legal Equality.

A frequent presenter and author on legal topics, Ms. Wilson was Editor-in-Chief of Life's Cheat Sheets by Jeff Wilson, a best selling book series to inspire young adults to develop fundamental life skills with shortcuts to achieving success.

Sharing the same passion for and advocacy on behalf of clients within the healthcare and skilled nursing industry, Excelas, LLC Founder & President, Jean Bourgeois, MBA, RHIA and Ms. Wilson have worked together to achieve successful outcomes, cultivate mutual respect, and recognize a profound commitment to positively impact the way healthcare is delivered.

While navigating the complex pre- and post-COVID healthcare landscape of acute-, short-, and long-term medical and rehab care, Excelas, LLC's Founder identified Ms. Wilson as the ideal candidate to succeed her as President when she steps away from day-to-day responsibilities.

Ms. Wilson's considerable accomplishments, dedication to community and professional integrity, along with her sincere desire and proven skills to help others resolve problems, will further propel Excelas, LLC's mission to position its clients' resources where they belong - in patient care.

Learn more: https://excelas1.com/

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/23-0313-s2p-bawilson-300dpi.jpg

Photo caption: Beth A. Wilson, Excelas, LLC President.

RELATED LINKS:
https://www.linkedin.com/in/beth-wilson-3528a826/

https://www.linkedin.com/in/jeancbourgeois/

Beth A. Wilson has been named President of Excelas, LLC, a national provider of medical record organization, retrieval, and analysis, helping healthcare organizations respond to claims - and litigation - brought against them. Excelas, LLC's announcement today says Ms. Wilson's tenure begins April 17, 2023.

Related link: https://excelas1.com/

Helen Mayberg to Keynote 2023 Bioelectronic Medicine Forum in New York City

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan.

The keynote speaker at this year's event is Helen Mayberg, Director of the Nash Family Center for Advanced Circuit Therapeutics at Mount Sinai School of Medicine. Mayberg is recognized as one of the pioneers of neuromodulation for treating psychiatric disorders. She will speak on the topic, "Pharmacological therapies simply aren't enough."

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate sessions at the event

The founders and CEOs of several promising bioelectronic medicine startups will also present at the conference. Entrepreneur presenters Brad Schmidt, CEO of Panaxium, which is developing a new "iontronic" brain interface, Marc Powell, CEO of Reach Neuro, which has developed a new stroke rehabilitation therapy, Luca Ravagnan, CEO of WISE srl, an Italian firm developing thin, stretchable brain electrodes, and Karen Crow, CEO of NeuroGeneces, which has developed a sleepband that performs brain health assessment using A.I. and EEG data.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor and Valtronic and Velentium are Silver Sponsors.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This sixth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry."

For more information on the 2023 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Sixth Annual Bioelectronic Medicine Forum will take place on April 4, 2023. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Related link: https://www.neurotechreports.com/

NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group (PSG) Announces Artemetrx Extend – Revolutionary Drug Management Reporting Tool Offers Powerful User Insights

DALLAS, Texas /ScoopCloud/ -- Artemetrx®, the industry's most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.

"Artemetrx delivers swift and easy access to valuable drug management insights. With Artemetrx Extend, our clients will be able to further tap into the rich integrated dataset of the Artemetrx platform," said Libby Johnson, PSG Chief Data and Analytics Officer. "Artemetrx Extend continues our long legacy of client advocacy and innovation, as the industry's best keeps getting better."

Can your organization quickly get its data-driven questions answered? Most plans get bogged down waiting for custom analytics when Artemetrx can respond in seconds. The major capabilities now available within Artemetrx Extend, through powerful filtering and drill downs, include the ability to:

* Determine how many members have medical claims associated with a diagnosis for a specific group

* Analyze the specific diagnoses that a particular drug is prescribed to treat for a population based on claims history

* Model the financial impact of switching from one preferred medication to another

* View spend and trend statistics on all drugs (specialty/non-specialty, medical/pharmacy) or search based on National Drug Code, Healthcare Common Procedure Coding System, or drug name

There are two versions of Artemetrx Extend available: Base Access is available for all users, and Power User Access is optional, allowing for custom report and dashboard building and the ability to save and share reports.

Artemetrx is a proprietary industry-leading web-based software for integrated drug management developed by Pharmaceutical Strategies Group. Artemetrx Extend is the latest in a series of innovations on the Artemetrx platform.

Learn more about how Artemetrx Extend: https://link.psgconsults.com/Artemetrx.Extend

About Artemetrx®

Artemetrx is a proprietary SaaS platform developed by Pharmaceutical Strategies Group (PSG), an EPIC company. As one of the first technology solutions in the market to integrate pharmacy and medical claims data for specialty drug cost management, Artemetrx continues to provide market-leading specialty drug insights to payers. It delivers unparalleled intelligence and line-of-sight into serious challenges perpetuating out-of-control drug costs and compromised patient outcomes.

More information: https://www.psgconsults.com/discoverartemetrx

About Pharmaceutical Strategies Group (PSG)

Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG's innovative drug management solutions, including Artemetrx®, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year.

More information: https://www.psgconsults.com/

Artemetrx®, the industry's most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.

Related link: https://www.psgconsults.com/

Docsnap Partners with FlexCare Digital Health to Expand Services to Members, Families, Employers, Veterans, Medicare, and Medicaid Patients

ATLANTA, Ga. /ScoopCloud/ -- Docsnap, the first nationwide Consumer Health Utility, supports consumers leveraging their HIPAA rights to take ownership of all their medical records. Docsnap announced today its partnership with FlexCare Digital Health to expand access to quality healthcare services for members, families, employees, veterans, Medicare, and Medicaid Patient services. This partnership allows docsnaps' members to benefit from Telemedicine & TeleDentistry virtually, 24/7/365. Docsnap and FlexCare will start their partnership immediately to begin providing digital health access to all docsnap members and enterprise customers.

"Docsnap is excited to welcome FlexCare Digital Health to our partnership family, filling a vital need for our members. As the founder of docsnap and the father of a daughter with a chronic health issue, having access to virtual care visits when it's needed and not when you are told you can have it is critical for the reduction of pain and suffering, stress and anxiety, and the high cost of avoidable urgent care and emergency room visits," said founder Dr. Anthony Mari.

According to UnitedHealth Group research, two-thirds of hospital ED visits annually by individuals in the United States - 18 million out of 27 million - are avoidable. By docsnap and FlexCare providing access 24/7 to compensate for the nation's shortage of Primary Care providers, docsnap provides members "peace-of-mind," knowing they have access to advice about urgent and emergent care when they need it!

"FlexCare is excited to partner with docsnap in providing virtual care services for their Consumer Health Utility," said Principal Lee Shoemake. "We view this as a tremendous opportunity to provide a valuable benefit to millions of docsnap members."

A virtual consult by a licensed physician or dentist from the comfort and convenience of a computer or mobile device can help members get the care they need when they need it.

FlexCare is committed to fulfilling this important member benefit, which will not only assist with providing on demand care, but it will also close the gap of availability to digital health providers.

Learn more: https://flexcare.com/

About FlexCare

FlexCare Digital Health is a leading provider of online and on-demand healthcare delivery services to private and public employers, associations, brokers, school systems, and more. By using digital health services instead of more expensive urgent care and ER visits, FlexCare cuts unnecessary costs and keeps members smiling, instead of waiting.

In addition to Telemedicine, FlexCare also offers TeleDentistry, Virtual Primary Care, Dermatology, Behavioral Health, Telespine and other digital health services.

FlexCare seamlessly provides multiple member benefits, either bundled or unbundled, which improves not only access, but cuts the overall cost of care for members and their dependents.

Twitter: https://twitter.com/FlexCarePlus

LinkedIn: https://www.linkedin.com/company/flexcare-telemedicine/

Facebook: https://facebook.com/FlexCarePlus

Instagram: https://instagram.com/FlexCarePlus

Docsnap, the first nationwide Consumer Health Utility, supports consumers leveraging their HIPAA rights to take ownership of all their medical records. Docsnap announced today its partnership with FlexCare Digital Health to expand access to quality healthcare services for members, families, employees, veterans, Medicare, and Medicaid Patient services.

Related link: http://flexcare.com/

MediSked Named Top 10 Population Health Management Solution Provider For Second Year

ROCHESTER, N.Y. /ScoopCloud/ -- MediSked, LLC was named as one of the Top 10 Population Health Management Solution Providers of 2022 by Medhealth Outlook, after being named one of the Top 10 Population Health Management Solution Companies of 2021 by Healthcare Tech Outlook.

These issues of each magazine contain an annual listing of ten companies that are at the forefront of providing Population Health Management solutions and impacting the industry.

MediSked has been a trusted technology partner to health and human services organizations across the country since 2003, delivering comprehensive Software as a Service (SaaS) solutions via a person-centered technology model. MediSked offers a full-featured, modular software ecosystem for agencies in the home and community-based services (HCBS) and long-term services and supports (LTSS) industries.

MediSked's population health management offering is distinctive from others in that MediSked is one of the few premier technology vendors that has in-depth experience in supporting statewide Medicaid transformation. With MediSked's population health management solution suite, agencies can generate extensive analytics to identify opportunities that improve individual and population-level outcomes.

To learn more about MediSked's population health management solution, visit https://www.medisked.com/

To view MediSked's 2022 award in Medhealth Outlook, visit https://medhealthoutlook.com/population-health-edition-2022/

About MediSked:

MediSked is the leading brand in holistic solutions that improves lives, drives efficiencies, and generates innovations for health and human service organizations that support our community. MediSked solutions combine to provide innovative, person-centered technology that improves outcomes and quality, while reducing costs for individuals receiving home and community-based services and long-term services and supports through government & oversight, care coordination/payer and provider agencies. MediSked has supported clients across the United States since 2003.

MediSked, LLC was named as one of the Top 10 Population Health Management Solution Providers of 2022 by Medhealth Outlook, after being named one of the Top 10 Population Health Management Solution Companies of 2021 by Healthcare Tech Outlook.

Related link: https://www.medisked.com/

MediSked Joins the Iowa Association of Community Providers (IACP) as a Strategic Business Partner

URBANDALE, Iowa /ScoopCloud/ -- Furthering its dedication to providing person-centered software solutions in Iowa, MediSked has joined the Iowa Association of Community Providers (IACP) as a Strategic Business Partner. IACP supports Iowa community providers so they can fully support Iowans in need of behavioral health and disability services.

As a Strategic Business Partner, MediSked will support the community providers that employ over 40,000 Iowans and provide services in all 99 counties of Iowa. This allows MediSked to connect with providers and ultimately help them to build efficiencies, support business operations, and enhance service quality.

"We are excited to join IACP in our shared dedication to improving lives and creating organizational efficiencies for all Iowans," said Rachel Hendrickson, Associate Director of Strategic Growth at MediSked.

IACP has been relentlessly advocating on behalf of mental health and disability service providers for more than 35 years. IACP partners with more than 125 community-based organizations to provide a wide range of resources to their management and staff (30,000+ people) to ensure that provider needs are being met.

About MediSked

MediSked is the leading brand in holistic solutions that improves lives, drives efficiencies, and generates innovations for health and human service organizations that support our community. MediSked solutions combine to provide innovative, person-centered technology that improves outcomes and quality, while reducing costs for individuals receiving home and community-based services and long-term services and supports through government & oversight, care coordination/payer and provider agencies. MediSked has supported clients across the United States since 2003.

LEARN MORE:

https://www.medisked.com/

https://www.iowaproviders.org/

Furthering its dedication to providing person-centered software solutions in Iowa, MediSked has joined the Iowa Association of Community Providers (IACP) as a Strategic Business Partner. IACP supports Iowa community providers so they can fully support Iowans in need of behavioral health and disability services.

Related link: https://www.medisked.com/

Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Mudit Jain, Ph.D., general partner at VC firm Treo Ventures, will keynote the conference. Dr. Jain has more than two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in the U.S., Ireland, and India. He is the co-founder of NuXcel, a medical device accelerator, and also serves as chairman of the board of ShiraTronics Inc., a NuXcel spinoff. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

"The neurotechnology industry has emerged as one of the most promising areas of healthcare technology, and Neurotech Reports has been following the space longer than any other organization," said James Cavuoto, editor and publisher at Neurotech Reports. "This year's conference-our 22nd annual-will offer unique insights for management and investment professionals involved with the industry."

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to reimbursement, securing funding, the new competitive landscape in neuromodulation, deep-brain stimulation, and neurorehabilitation. New this year is a session devoted to privacy, security, and ethics in neurotechnology.

Among the companies presenting this year are gBrain, a Korean manufacturer of graphene-based brain engineering systems, Motif Neurotech, a Texas developer of compact implanted brain stimulation devices for treating depression, and REVAI, a Canadian manufacturer of AI-powered vagus nerve stimulation systems for learning and wellness applications. Other presenting companies are Neural Dynamics Technologies, NeuroSigma, Roga Life, NXTStim, PathMaker Neurosystems, NeuronOff, WISE Srl, Sana Health, and Zeto Inc.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic and MCRA are Silver Sponsors, and the Cleveland FES Center is Bronze Sponsor.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Dosaggio™ by SottoPelle® Partners with PatientNow

SCOTTSDALE, Ariz. /ScoopCloud/ -- Dosaggio™ by SottoPelle® and PatientNow announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

This collaboration offers medical providers a powerful and seamless integration of capabilities for bioidentical hormone replacement therapy practices.

This partnership brings together PatientNow's robust functional EHR with the advanced and powerful Dosaggio™ hormone dosing tool, enabling medical providers to expand their functional medicine practices into the bioidentical hormone therapy arena.

PatientNow is a functional, full-service EHR that offers customized and integrated scheduling, charting, billing, reporting, prescription management, and treatment plan solutions for medical practices. The PatientNow EHR offers flexibility for each provider's needs - all with fair pricing.

The Dosaggio™ bioidentical hormone pellet therapy dosing application allows medical providers to optimize their patient's hormone health through precise, individualized hormone dosing. Dosaggio™ by SottoPelle® offers providers a proprietary online hormone dosing calculator that uses the patient's unique health data to calculate a precise, individualized BHRT dose. Dosaggio™ combines a powerful algorithm with on-screen clinical guidance that enables medical providers to approach each patient's hormone health care in an individualized manner.

The integration of these two platforms allows medical providers to pull patient data such as lab work, demographics, past hormone therapy notes, and other documentation from their PatientNow EHR into the Dosaggio™ dosing application. This eliminates the need for double documentation and helps seamlessly maintain continuity of care for BHRT patients.

"The Dosaggio and PatientNow integration will help providers bring quality care to their patients who suffer from hormonal imbalance," stated CarolAnn Tutera, CEO of Dosaggio™ by SottoPelle®. "It is our mission to help providers bring individualized care to more patients, to help them age gracefully."

Practices that are currently using PatientNow's EHR can conveniently set up their Dosaggio™ account by visiting the integrations page within their account. Medical providers who are interested in learning more about this exciting integration may visit: https://sottopelle.health.

Dosaggio™ by SottoPelle® and PatientNow announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

Related link: https://www.sottopelletherapy.com/

iRxReminder chooses CAREier for medical device support to empower patient population

POTOMAC, Md. /ScoopCloud/ -- iRxReminder, a medication monitoring platform service, recently teamed up with CAREier, the revolutionary medical device communication company, to ensure its patients remain safe and independent.

"We're thrilled that iRxReminder chose to partner with us to ensure they meet their mission to empower patients to greater stability and increase health agency revenue," Ryan Bass, CEO, CAREier says.

Anthony Sterns, founder, iRxReminder, first met Bass through the NewChip Accelerator Program which connects new and experienced investors to business and real estate investment opportunities around the nation.

"When our group shared what each of us was doing, I knew immediately that we needed CAREier's device information tracking and notification services to ensure we always had a way to manage devices should they ever need to be exchanged or recalled," Sterns says. "CAREier backs us up and gives us the ability to interact directly with customers and to act quickly as needed."

For example, if there's a manufacturer's component defect such as a motor fail in a specific lot of medical devices, CAREier is responsible for quick communication to those customers. It will also resolve the situation through a seamless medical device exchange.

"CAREier's software is exactly what we - and our customers need - for peace of mind when it comes to a fully functioning product to support their medications," Sterns adds.

About CAREier:

CAREier is revolutionizing medical device communications to finally include the patient. Its mission is to create a complete communication ecosystem between regulators, medical device manufacturers, healthcare providers, physicians and patients to transmit urgent messages in near real-time with confirmed receipt and acknowledgement. It provides a framework for seamless communication across the entire medical device spectrum for an automated, immediate, and secure delivery of patient electronic device information, device recalls, standards of care reminders and more.

For more information: https://careier.com/

About iRxReminder, LLC:

iRxReminder is a Cleveland, Ohio-based medication monitoring platform service provider focused on moving mental health patients from crisis to control by monitoring medication taking to achieve and sustain independence. It's completely patient-centered and addresses accountable care and population-health-management goals, so patients can achieve high medication adherence. iRxReminder provides effortless monitoring of medication taking and triggers interventions by staff, as needed, to improve healthcare outcomes.

Additionally, the data from monitoring and intervention activities allows agencies to complete more reimbursable activities to help increase their revenue up to 70 percent.

iRxReminder works with Harvard University, The University of Michigan Cancer Center, George Mason University, Case Western Reserve University, Kent State University, University of Wisconsin School of Medicine and Summa Health System. The company plans to evolve with FDA clearance of the iLidRx, its Internet of Things pill dispenser that verifies medication dispensing as a 510(k) Class II medical device.

The iRxCapture app, available in the Apple App and Google Play stores.

For more information: https://www.irxreminder.com/

iRxReminder, a medication monitoring platform service, recently teamed up with CAREier, the revolutionary medical device communication company, to ensure its patients remain safe and independent. CAREier is revolutionizing medical device communications to finally include the patient.

Related link: https://careier.com/

Engage By Cell Announces Rebrand of Divisions

SAN FRANCISCO, Calif. /ScoopCloud/ -- Today, Engage by Cell announces the rebranding of former divisions Guide by Cell, Give by Cell, and Train by Cell to create a cohesive and clear client experience. Engage by Cell has served as a catchall for the growing divisions under the "by Cell" umbrella for years and will now serve as the company's sole iteration.

The tech company will release a new website, https://www.engagebycell.com/, updated services, and a fresh vision for user-friendly mobile tools in a variety of domestic and international organizations.

Engage by Cell has grown to serve healthcare, education, nonprofit, government, occupational safety, enterprise, cultural, and several other industries.

This rebrand will encompass the core technologies: Text Messaging, Mobile Web Apps, GPS Wayfinding, Call Services, Payment Processing, and Digital Cards. These platforms may work together or independently to create the desired client experiences.

"With the tech and mobile world booming, we are constantly upgrading services and adding new platforms. Our new organizational structure will allow us to offer a cohesive, unified front moving forward," says David Asheim, Founder and Chief Executive Officer of Engage by Cell.

About Engage by Cell:

Founded 16 years ago in San Francisco, CA, Guide by Cell began by providing mobile touring solutions to cultural venues. Over the years the "by Cell" divisions have grown to serve clients like Smithsonian Institution, Aon, Bloomberg, USPS, Banner Health, Central Park Conservancy, American Cancer Society, Mary Kay, and many more by providing innovative ways for organizations to use mobile technologies to improve the efficiency of their operation.

For more information, visit: https://www.engagebycell.com/ or call (415) 297-6677

Today, Engage by Cell announces the rebranding of former divisions Guide by Cell, Give by Cell, and Train by Cell to create a cohesive and clear client experience. Engage by Cell has served as a catchall for the growing divisions under the "by Cell" umbrella for years and will now serve as the company's sole iteration.

Related link: https://www.engagebycell.com/

World Renowned Patient Safety Champion Joins CAREier Advisory Board

POTOMAC, Md. /ScoopCloud/ -- CAREier, Inc., the revolutionary medical device communication company, is building an advisory board of patient safety and healthcare industry powerhouses. Its latest addition is world renowned, Peter J. Pronovost, M.D., Ph.D., F.C.C.M., a critical care physician and prolific researcher who has published more than 800 peer review publications; his scientific work has saved thousands of lives.

"We're absolutely thrilled that Dr. Pronovost has joined our advisory board," Ryan Bass, founder and CEO, CAREier says. "As a global thought leader who has influenced U.S. and global health policy, I'm confident he will help us to champion a new chapter in healthcare IT, patient safety and medical device communication."

When Bass founded CAREier, he sought to turn the world of medical device communication on its head. He didn't just want an incremental improvement to the processes used today, he wanted to change the system - and eventually the world's standards for patient level communication expectations. There's no other platform like it.

CAREier provides a framework for seamless communication across the entire medical device spectrum for an automated, immediate, and secure delivery of patient electronic device information, device recalls, standards of care reminders and more.

"We really work from the top down," Bass says. "Everyone from the FDA to the patient is part of our holistic network. And we're sure that our advisory board will help us to build a better medical device communication ecosystem. I'm truly humbled and honored to have Dr. Pronovost on board."

In 2005, Dr. Pronovost was involved in the launch of a leading solution to the medical device communication problem and since then, he says he hasn't seen any real innovation - that is - until now.

"Almost 20 years ago, I was involved in developing systems and processes related to the recalls experienced by health systems. Since then, innovation in this space has been slow and I was excited when CAREier approached me with their pioneering solution. CAREier is not an incremental improvement to today's workflows, but is a transformative approach to more efficiently and effectively manage recalls and improve safety."

About Peter J. Pronovost, M.D., Ph.D., F.C.C.M.:

Dr. Pronovost is the Chief Quality and Clinical Transformation Officer at University Hospitals. His entrepreneurial patient safety endeavors have earned him high-profile accolades - including being named one of the 100 most influential people in the world by "Time" magazine, receiving a coveted MacArthur Foundation "genius grant" in 2008.

In his current role, he fosters ideation and implementation for new protocols to eliminate defects in value to enhance quality of care; develop new frameworks for population health management for its more than 1 million patients; and manage the UH Accountable Care Organization (ACO) Network - one of the nation's largest. His primary focus is to keep people "Healthy at Home." In just 12 months, one of his concepts fueled a reduction in annual costs per patient in the UH ACO by nine percent.

He's also served as the senior vice president for Patient Safety and Quality at Johns Hopkins Medicine as well as the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. While there, he worked to eliminate all harms in one health system following on his success in eliminating one harm in most health systems across the U.S.

For a complete bio: https://www.uhhospitals.org/about-uh/leadership/uh-system-leadership/peter-pronovost

About CAREier:

CAREier is revolutionizing medical device communications to finally include the patient. Its mission is to create a complete communication ecosystem between regulators, medical device manufacturers, healthcare providers, physicians and patients to transmit urgent messages in near real-time with confirmed receipt and acknowledgement.

For more information: https://careier.com/

CAREier, Inc., the revolutionary medical device communication company, is building an advisory board of patient safety and healthcare industry powerhouses. Its latest addition is world renowned, Peter J. Pronovost, M.D., Ph.D., F.C.C.M., a critical care physician and prolific researcher who has published more than 800 peer review publications; his scientific work has saved thousands of lives.

Related link: https://careier.com/

New, Patented Device for Quick, Painless, Non-Invasive Elimination of Hemorrhoids Now Available with All Rights for Manufacture

LOS ANGELES, Calif. /ScoopCloud/ -- ProNova Partners, a seventeen-year-old California based Mergers and Acquisitions firm, has been commissioned to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive, device to eliminate hemorrhoids. Use of the device requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital.

This technology has yielded a painless, non-invasive, no anesthesia needed device to eliminate hemorrhoids in under 2 minutes. The procedure can be performed in any medical setting.

"Over half of adults suffer from this affliction at one time or another," stated Rick Carlson founder and CEO of ProNova Partners. "This Doctor developed device offers a fast, painless and permanent solution."

Carlson's firm has helped the expansion or sale of some 400 companies in a wide variety of market segments.

This latest commission for ProNova is designed to structure movement of the patent, sale, and manufacturing rights of a much-needed device to an outside company. The goal is quickly move the technology out and into the medical marketplace. The product, developed and currently sold on a limited basis in the US, was originated by a gastroenterologist. It is currently sold directly to physicians of different specialties, including gastroenterologists, colorectal surgeons, GYNs, urologists and primary care physicians. The biggest targeted audience is gastroenterologists.

"Huge numbers of patients now no longer need to use ineffective creams or receive painful, invasive surgery," concluded Carlson. "This device offers a permanent, painless solution."

For detailed information go to: https://pronovapartners.com/engagement/patented-medical-device-company-for-hemorrhoid-removal-for-sale/

ProNova Partners, a seventeen-year-old California based Mergers and Acquisitions firm, has been commissioned to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive, device to eliminate hemorrhoids. Use of the device requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital.

Related link: https://www.pronovapartners.com/

AI Radiology and Emerging Medical Technology Venture Capital Investment Group Now Open to Outside Participation

LOS ANGELES, Calif. /ScoopCloud/ -- Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

"This venture capital investment partnership was founded in 2018," announced Rick Carlson, CEO of ProNova Partners. "On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies."

"The group is owned and operated by three managing partners with broad ranging domain expertise," continued Carlson. "We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor's edge of Artificial Intelligence in medical technology." Carlson's company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.

"The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies," concluded Carlson.

"The investment firm's distinguished Managing Partners' combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector."

For detailed information go to: https://pronovapartners.com/engagement/ai-radiology-and-emerging-technology-firm-for-sale/

Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

Related link: https://www.pronovapartners.com/

By Light Awarded $82M VA Contract

MCLEAN, Va. /ScoopCloud/ -- By Light Professional IT Services LLC (By Light) has been awarded the My HealtheVet (MHV) Development, Security and Operations (DevSecOps) contract by the Department of Veterans Affairs (VA). Valued at $82M over five (5) years, this contract provides for the continued support and development of VA's Veteran-facing Electronic Health portal.

"Team By Light considers it an honor to continue our long and valued partnership with VA to provide innovative DevSecOps solutions to the MHV Program with a Scaled Agile and Digital Services Playbook approach," says Bill Sackewitz, By Light Senior VP for Digital Transformation. "Our team has invested heavily in DevSecOps, User Centered Design, and Lean Agile Product Delivery methods to hasten and improve value delivered to the customer. Our mission in By Light's Chief Strategy Office is to help our teams and our clients adopt new ways of working that lead to better user outcomes."

The MHV patient portal provides healthcare communications and coordination for millions of Veterans, caretakers, and providers. The MHV program is a nationwide initiative intended to improve the overall health of Veterans. It provides an eHealth portal, a secure environment where Veterans can view and manage their personal health record online and access health information, health assessments, and electronic services. Online health resources will enable and encourage patient/provider collaboration, as clinicians will be able to communicate with Veterans more easily.

The online environment will complement existing Veterans Health Administration (VHA) clinical business practices and be transformational in the way health care is delivered and managed. Like other VA systems MHV will eventually be integrated into VA.gov that will be accessible to Veterans from MHV, or other web portals as identified by the government.

"Our team has been supporting the development and expansion of MHV since 2012 and is dedicated to furthering the evolution of one of the U.S. Government's largest and most important technical programs benefiting those who have served," states Matt Bain, MHV Program Director at By Light. "We are very proud of our ten years of supporting MHV eHealth delivery capabilities and look forward to further deliver new and innovative solutions that support VA's Office of Connected Care ecosystem and improve the experience for Veterans and their care givers."

"We are happy to have By Light back and to continue the great work we have done together over the past decade," notes Greg Kirk, MHV Program Manager. "The MHV solution will continue to evolve with the DevSecOps contract, and the results will ultimately deliver better products and services faster to the Veterans."

About By Light:

By Light Professional IT Services LLC (https://www.bylight.com) headquartered in McLean, Virginia, is an ISO 9001, 20000-1, and 27001 registered and CMMI Level 3 rated systems integrator that provides innovative IT, infrastructure solutions, and full spectrum cyberspace operations for U.S. Federal and State Government Agencies. By Light has extensive success with VA and across the DoD, successfully implementing technical solutions that integrate commercial best practices to meet the needs of government.

By Light Professional IT Services LLC (By Light) has been awarded the My HealtheVet (MHV) Development, Security and Operations (DevSecOps) contract by the Department of Veterans Affairs (VA). Valued at $82M over five (5) years, this contract provides for the continued support and development of VA's Veteran-facing Electronic Health portal.

Related link: https://www.bylight.com/

MediSked Partners with Medicaid Health Plans of America (MHPA) to Further Support Managed Care

ROCHESTER, N.Y. /ScoopCloud/ -- Furthering its dedication to providing technology solutions to payers in the health and human services industry, MediSked has signed a corporate partnership agreement with Medicaid Health Plans of America (MHPA), MediSked announced today.

Founded in 1995, MHPA is the leading national trade organization focusing solely on the interests of the Medicaid managed care industry. MHPA's members include over 130 health plans, known as managed care organizations (MCOs), that serve over 40 million Medicaid enrollees in 40 states, the District of Columbia and Puerto Rico.

"MHPA is thrilled to have MediSked join us as a Bronze Partner," said Craig A. Kennedy, MHPA President and CEO. "For nearly two decades MediSked has been an invaluable technology resource and partner to health and human service organizations across the United States, changing lives for the better and increasing efficiency, as well as driving innovations that support the health care community. We look forward to working with them in our efforts to increase access to quality, affordable health care for all."

MediSked is one of the few premier technology vendors that has in-depth experience in supporting statewide Medicaid transformation using integrated end-to-end solutions that were built on the foundation of the federal Health Home State Plan.

As a Bronze Partner, MediSked will be working in partnership with MHPA to promote policy and operational solutions that enhance the delivery of quality care for Medicaid enrollees through improved access and cost-effective services.

"We are excited to join MHPA in our shared dedication to improving outcomes and quality of life for Medicaid-enrolled individuals across the country," said Rachel Hendrickson, Associate Director of Strategic Growth at MediSked.

About MediSked:

MediSked is the leading brand in holistic solutions that improves lives, drives efficiencies, and generates innovations for health and human service organizations that support our community. MediSked solutions combine to provide innovative, person-centered technology that improves outcomes and quality, while reducing costs for individuals receiving home and community-based services and long-term services and supports through government & oversight, care coordination/payer and provider agencies. MediSked has supported clients across the United States since 2003.

Learn more at https://www.medisked.com/.

Furthering its dedication to providing technology solutions to payers in the health and human services industry, MediSked has signed a corporate partnership agreement with Medicaid Health Plans of America (MHPA), MediSked announced today.

Related link: https://www.medisked.com/

Neurosoft Bioelectronics Receives Nearly $3 Million in Funding

NEW YORK, N.Y. /ScoopCloud/ -- Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant. Additionally, the firm secured a $100,000 convertible note from the Fongit Innovation Fund.

Proceeds will fund continued development of the company's soft flexible electrodes to be marketed as SOFT ECoG™, a family of implantable devices which can seamlessly interface with the brain. The novel devices are up to 1000x softer and 2x thinner than clinical electrodes, with integrated electrode sites up to 100x smaller, making them suited for high-resolution recording and stimulation of the brain for up to thirty days. Their conformability and softness make them ideally suited for placement in the sulci of the brain - hard to reach areas of the brain where many disorders may best be treated. The deep folds of a sulcus are inaccessible for other electrodes while SOFT ECoG can be safely and precisely placed for stimulation and recording.

"Given that 70% of the surface of the brain is buried in sulci, it was critical to develop a technology that could safely and effectively work in those spaces," said Neurosoft Bioelectronics' CEO, Nicolas Vachicouras, Ph.D. "We're eager to put these significant funds toward clinical testing and regulatory approval of SOFT ECoG in the upcoming months, which will simultaneously drive progress of SOFT TINNIT. Together, these products have the potential to bring relief to epilepsy, brain tumor, and tinnitus patients, and in the future will impact those living with other neurological disorders such as deafness, blindness, tetraplegia, and chronic pain."

Vachicouras will present an update about the company and technology at the Bioelectronic Medicine Forum in New York today.

Most of the funds are designated for the further development of SOFT ECoG however, the innovations made will simultaneously advance the company's second product, SOFT TINNIT™. SOFT TINNIT is a chronic implant to perform closed-loop neuromodulation of the cortex to provide relief for patients suffering from severe tinnitus. Severe tinnitus, which has no cure, affects more than 7 million people in the U.S. and Europe.

Learn more: https://www.neurosoft-bio.com/technology

About Neurosoft Bioelectronics

Neurosoft Bioelectronics Ltd. is a Swiss medtech spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL). Neurosoft Bioelectronics develops next generation soft implantable electrodes to interface with the brain for the treatment of severe neurological disorders. Its main product is a fully implantable closed-loop Brain-Computer Interface (BCI) to treat severe tinnitus, a condition that affects 7M people in the US and Europe, of which 7% attempt suicide every year. It is also developing a family of subdural electrodes intended for monitoring during brain tumor and epilepsy resection surgery.

Learn more at: https://www.neurosoft-bio.com/

RELATED LINKS:

https://neurotechreports.com/pages/bioelectronic-medicine-forum.html

Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.

Related link: https://www.neurosoft-bio.com/